针对性治疗喘的机会和挑战
Ioana Agache1, Magdalena Zemelka-Wiacek2, Radosław Gawlik3
1Faculty of Medicine, Transylvania University, Brasov, Romania.
The journal of allergy and clinical immunology. In practice
|November 28, 2025
概括
针对性喘治疗正在为特定患者推进,重点是定义缓解,分层轻度喘,并发现生物标志物. 实施需要解决资源障碍,以获得更好的患者结果.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 精准医学是一门精准的医学.
背景情况:
- 有针对性的喘治疗是一个新兴的目标,但尚未成为标准护理.
- 中欧和南欧过敏和喘联盟 (CSEA3) 2025年会议的专家见解为未来的方向提供了信息.
- 目前的喘管理途径需要改进,以实现个性化的方法.
研究的目的:
- 为推进有针对性的喘管理概述主要优先事项.
- 确定实施喘分层护理的策略.
- 为应对个性化喘治疗采用的挑战.
主要方法:
- 审查2025年CSEA3会议的专家讨论和见解.
- 针对性喘治疗的重点优先事项的识别和综合.
- 对分层喘护理实施的障碍和促进因素的分析.
主要成果:
- 确定了四个主要优先事项:定义缓解,通过分层管理轻度喘,生物标志物发现和优化实施.
- 根据内型和风险概况的患者分层可能会改善轻度喘管理.
- 需要预测性,护理点生物标志物和实施数字工具的验证.
结论:
- 推进向性喘治疗需要普遍接受的缓解的定义.
- 分层护理,生物标志物发现和解决实施障碍对于个性化喘管理至关重要.
- 协调努力至关重要,以将个性化治疗的进步转化为可持续的,改善患者的结果,特别是在资源有限的环境中.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K


